Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
23.00
-0.38 (-1.63%)
At close: Oct 15, 2024, 4:00 PM
22.22
-0.78 (-3.39%)
After-hours: Oct 15, 2024, 4:06 PM EDT
Upstream Bio Revenue
Upstream Bio had revenue of $1.15M in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to $2.22M. In the year 2023, Upstream Bio had annual revenue of $2.38M with 96.37% growth.
Revenue (ttm)
$2.22M
Revenue Growth
+96.37%
P/S Ratio
29.48
Revenue / Employee
$58,447
Employees
38
Market Cap
1.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.38M | 1.17M | 96.37% |
| Dec 31, 2022 | 1.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionUPB News
- 11 hours ago - Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 4 days ago - Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut - Reuters
- 5 days ago - Upstream Bio raises $255 mln in US IPO - Reuters
- 5 days ago - Upstream Bio Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 27 days ago - Respiratory disorder biotech Upstream Bio files for a $100 million IPO - Renaissance Capital
- 27 days ago - Upstream Bio IPO Registration Document (S-1) - SEC